stockrowAMN Healthcare Services Inc
AMN Healthcare Medical Care Facilities
AMN Healthcare Services Inc’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 8.49% from fiscal 2024.
- Revenue
- +13.1%
- EPS
- +11.8%
- Free cash flow
- −389.4%
- Total debt
- −18.9%
Quarter to September 2026, against a year earlier
Follow AMN
Alert me
AMN Healthcare Services Inc (AMN) EV/Sales
As of 5 November 2026, AMN Healthcare Services Inc (AMN) trades at a EV/Sales of 0.7×. Over the past ten years it has ranged from 0.3× (April 2026) to 2.1× (September 2021); the current reading is higher than 14% of that period. That is below the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.5× | (25.23%) |
| FY2024 | 0.7× | (42.23%) |
| FY2023 | 1.1× | 8.21% |
| FY2022 | 1.1× | (35.59%) |
| FY2021 | 1.6× | (4.02%) |
| FY2020 | 1.7× | 9.57% |
| FY2019 | 1.6× | 6.43% |
| FY2018 | 1.5× | 8.22% |
| FY2017 | 1.3× | 14.89% |
| FY2016 | 1.2× | 4.04% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 0.5× | 12.22% |
| Jun 2026 | 0.5× | 82.89% |
| Mar 2026 | 0.3× | (46.66%) |
| Dec 2025 | 0.5× | (13.52%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AGL Agilon Health, Inc. compare | 0.3× |
| ARDT Ardent Health, Inc. compare | 0.4× |
| ASTH Astrana Health, Inc. compare | 0.6× |
| AMN AMN Healthcare Services Inc | 0.6× |
| HCSG Healthcare Services Group, Inc. compare | 0.8× |
| PNTG The Pennant Group, Inc. compare | 1.3× |
| ADUS Addus HomeCare Corporation compare | 1.5× |
| NUTX Nutex Health Inc. compare | 1.7× |
| SNDA Sonida Senior Living, Inc. compare | 4.8× |
| Medical Care Facilities industry median | 1.4× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)